Cargando…
The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients
INTRODUCTION: Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174663/ https://www.ncbi.nlm.nih.gov/pubmed/25175389 http://dx.doi.org/10.1186/s13054-014-0487-z |
_version_ | 1782336374156820480 |
---|---|
author | Dejam, Andre Malley, Brian E Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra Aziz Pinto, Duane S Celi, Leo Anthony |
author_facet | Dejam, Andre Malley, Brian E Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra Aziz Pinto, Duane S Celi, Leo Anthony |
author_sort | Dejam, Andre |
collection | PubMed |
description | INTRODUCTION: Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion, patient characteristics, and clinical context. The objective was to test whether age, comorbidities, and clinical context modulate the effect of transfusion on survival. METHODS: By using the multiparameter intelligent monitoring in intensive care II database (v. 2.6), a retrospective analysis of 9,809 critically ill patients, we evaluated the effect of RBC transfusion on 30-day and 1-year mortality. Propensity score modeling and logistic regression adjusted for known confounding and assessed the independent effect of transfusion on 30-day and 1-year mortality. Sensitivity analysis was performed by using 3,164 transfused and non-transfused pairs, matched according the previously validated propensity model for RBC transfusion. RESULTS: RBC transfusion did not affect 30-day or 1-year mortality in the overall cohort. Patients younger than 55 years had increased odds of mortality (OR, 1.71; P < 0.01) with transfusion. Patients older than 75 years had lower odds of 30-day and 1-year mortality (OR, 0.70; P < 0.01) with transfusion. Transfusion was associated with worse outcome among patients undergoing cardiac surgery (OR, 2.1; P < 0.01). The propensity-matched population corroborated findings identified by regression adjustment. CONCLUSION: A complex relation exists between RBC transfusion and clinical outcome. Our results show that transfusion is associated with improved outcomes in some cohorts and worse outcome in others, depending on comorbidities and patient characteristics. As such, future investigations and clinical decisions evaluating the value of transfusion should account for variations in baseline characteristics and clinical context. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-014-0487-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4174663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41746632014-09-26 The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients Dejam, Andre Malley, Brian E Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra Aziz Pinto, Duane S Celi, Leo Anthony Crit Care Research INTRODUCTION: Whether red blood cell (RBC) transfusion is beneficial remains controversial. In both retrospective and prospective evaluations, transfusion has been associated with adverse, neutral, or protective effects. These varying results likely stem from a complex interplay between transfusion, patient characteristics, and clinical context. The objective was to test whether age, comorbidities, and clinical context modulate the effect of transfusion on survival. METHODS: By using the multiparameter intelligent monitoring in intensive care II database (v. 2.6), a retrospective analysis of 9,809 critically ill patients, we evaluated the effect of RBC transfusion on 30-day and 1-year mortality. Propensity score modeling and logistic regression adjusted for known confounding and assessed the independent effect of transfusion on 30-day and 1-year mortality. Sensitivity analysis was performed by using 3,164 transfused and non-transfused pairs, matched according the previously validated propensity model for RBC transfusion. RESULTS: RBC transfusion did not affect 30-day or 1-year mortality in the overall cohort. Patients younger than 55 years had increased odds of mortality (OR, 1.71; P < 0.01) with transfusion. Patients older than 75 years had lower odds of 30-day and 1-year mortality (OR, 0.70; P < 0.01) with transfusion. Transfusion was associated with worse outcome among patients undergoing cardiac surgery (OR, 2.1; P < 0.01). The propensity-matched population corroborated findings identified by regression adjustment. CONCLUSION: A complex relation exists between RBC transfusion and clinical outcome. Our results show that transfusion is associated with improved outcomes in some cohorts and worse outcome in others, depending on comorbidities and patient characteristics. As such, future investigations and clinical decisions evaluating the value of transfusion should account for variations in baseline characteristics and clinical context. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-014-0487-z) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-30 2014 /pmc/articles/PMC4174663/ /pubmed/25175389 http://dx.doi.org/10.1186/s13054-014-0487-z Text en © Dejam et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Dejam, Andre Malley, Brian E Feng, Mengling Cismondi, Federico Park, Shinhyuk Samani, Saira Samani, Zahra Aziz Pinto, Duane S Celi, Leo Anthony The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title_full | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title_fullStr | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title_full_unstemmed | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title_short | The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
title_sort | effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174663/ https://www.ncbi.nlm.nih.gov/pubmed/25175389 http://dx.doi.org/10.1186/s13054-014-0487-z |
work_keys_str_mv | AT dejamandre theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT malleybriane theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT fengmengling theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT cismondifederico theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT parkshinhyuk theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT samanisaira theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT samanizahraaziz theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT pintoduanes theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT celileoanthony theeffectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT dejamandre effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT malleybriane effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT fengmengling effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT cismondifederico effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT parkshinhyuk effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT samanisaira effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT samanizahraaziz effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT pintoduanes effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients AT celileoanthony effectofageandclinicalcircumstancesontheoutcomeofredbloodcelltransfusionincriticallyillpatients |